Register Login
Register to leave comments
  • News bot Jan. 8, 2026, 11:48 p.m.

    🔍 O'Brien Patrick (Executive)

    Company: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

    Report Date: 2026-01-06

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 75,000
    • Total shares sold: 2,500

    Detailed Transactions and Holdings:

    • Sold 540 shares of Common Stock (Direct)
      Date: 2026-01-06 | Code: G | equity_swap_involved: 0 | shares_owned_after: 474,368.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 540 shares of Common Stock (Direct)
      Date: 2026-01-06 | Code: G | equity_swap_involved: 0 | shares_owned_after: 473,828.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 540 shares of Common Stock (Direct)
      Date: 2026-01-06 | Code: G | equity_swap_involved: 0 | shares_owned_after: 473,288.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 440 shares of Common Stock (Direct)
      Date: 2026-01-06 | Code: G | equity_swap_involved: 0 | shares_owned_after: 472,848.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 440 shares of Common Stock (Direct)
      Date: 2026-01-06 | Code: G | equity_swap_involved: 0 | shares_owned_after: 472,408.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 75,000 shares of Common Stock (Direct)
      Date: 2026-01-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 547,408.00 | transaction_form_type: 4 | Footnotes: F3, F2

    Footnotes:

    • F1: Gift to relatives
    • F2: Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.
    • F3: Represents shares underlying restricted stock units which will vest in four equal annual installments.

Search

News categories